NCT03404635View on ClinicalTrials.gov

Monotherapy Anticoagulation To Expedite Home Treatment of Venous Thromboembolism

CompletedOBSERVATIONAL
Enrollment

1,300

Participants

Timeline

Start Date

August 4, 2017

Primary Completion Date

May 8, 2020

Study Completion Date

May 8, 2020

Conditions
Venous Thromboembolism
Interventions
DRUG

Apixaban

Apixaban as standard of care for VTE

DRUG

Rivaroxaban

Rivaroxaban as standard of care for VTE

Trial Locations (2)

46202

Eskenazi Health System, Indianapolis

Indiana University Health Methodist Hospital, Indianapolis

Sponsors
All Listed Sponsors
collaborator

Bristol-Myers Squibb

INDUSTRY

collaborator

Pfizer

INDUSTRY

collaborator

Janssen Pharmaceuticals

INDUSTRY

lead

Indiana University

OTHER